Northern Trust’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6K | Hold |
|
|||||
|
2025
Q1 | $17.1K | Sell |
|
|||||
|
2024
Q4 | $29.3K | Sell |
|
|||||
|
2024
Q3 | $74.1K | Sell |
|
|||||
|
2024
Q2 | $341K | Buy |
|
|||||
|
2024
Q1 | $501K | Sell |
|
|||||
|
2023
Q4 | $700K | Buy |
|
|||||
|
2023
Q3 | $834K | Sell |
|
|||||
|
2023
Q2 | $1.92M | Buy |
|
|||||
|
2023
Q1 | $50.9K | Sell |
|
|||||
|
2022
Q4 | $200K | Sell |
|
|||||
|
2022
Q3 | $141K | Hold |
|
|||||
|
2022
Q2 | $269K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Sell |
|
|||||
|
2021
Q4 | $1.47M | Buy |
|
|||||
|
2021
Q3 | $1.42M | Buy |
|
|||||
|
2021
Q2 | $7.79M | Buy |
|
|||||
|
2021
Q1 | $779K | Buy |
|
|||||
|
2020
Q4 | $317K | Sell |
|
|||||
|
2020
Q3 | $332K | Buy |
|
|||||
|
2020
Q2 | $160K | Hold |
|
|||||
|
2020
Q1 | $125K | Buy |
|
|||||
|
2019
Q4 | $173K | Sell |
|
|||||
|
2019
Q3 | $199K | Buy |
|
|||||
|
2019
Q2 | $195K | Buy |
|
|||||
|
2019
Q1 | $133K | Sell |
|
|||||
|
2018
Q4 | $231K | Sell |
|
|||||
|
2018
Q3 | $350K | Buy |
|
|||||
|
2018
Q2 | $315K | Buy |
|
|||||
|
2018
Q1 | $31K | Buy |
|
|||||
|
2017
Q4 | $17K | Hold |
|
|||||
|
2017
Q3 | $33K | Hold |
|
|||||
|
2017
Q2 | $32K | Hold |
|
|||||
|
2017
Q1 | $45K | Buy |
|
|||||
|
2016
Q4 | $34K | Buy |
|
|||||
|
2016
Q3 | $50K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $122K | Sell |
|
|||||
|
2015
Q1 | $437K | Buy |
|
|||||
|
2014
Q4 | $566K | Buy |
|
|||||
|
2014
Q3 | $518K | Buy |
|
|||||
|
2014
Q2 | $612K | Buy |
|
|||||
|
2014
Q1 | $612K | Buy |
|